Feigal, Ellen G <br/><br/>
Perspective: communications with the Food and Drug Administration on the development pathway for a cell-based therapy: why, what, when, and how?  [electronic resource] 

 -  Stem cells translational medicine  Nov 2012 
 - 825-32 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2157-6564 
<br/><br/><label>Standard No.: </label>10.5966/sctm.2012-0104  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cell Transplantation<br/>Communication<br/>Humans<br/>United States<br/>United States Food and Drug Administration